Plumbagin attenuates traumatic tracheal stenosis in rats and inhibits lung fibroblast proliferation and differentiation via TGF-β1/Smad and Akt/mTOR pathways

References

• Wain JC Jr. Postintubation tracheal stenosis. Semin Thorac Cardiovasc Surg. 2009;21(3):284–289.
   PubMedGoogle Scholar
• Farzanegan R, Feizabadi M, Ghorbani F, et al. An overview of tracheal stenosis research trends and hot topics. Arch Iran Med. 2017;20(9):598–607.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Zhou L, Zhang T, et al. Anti-fibrosis activity of quercetin attenuates rabbit tracheal stenosis via the TGF-β/Akt/mTOR signaling pathway. Life Sci. 2020;250:117552.
   PubMed Web of Science ®Google Scholar
• Gelbard A, Donovan DT, Ongkasuwan J, et al. Disease homogeneity and treatment heterogeneity in idiopathic subglottic stenosis. Laryngoscope. 2016;126(6):1390–1396.
   PubMed Web of Science ®Google Scholar
• Gelbard A, Shyr Y, Berry L, et al. Treatment options in idiopathic subglottic stenosis: protocol for a prospective international multicentre pragmatic trial. BMJ Open. 2018;8(4):e022243.
   PubMed Web of Science ®Google Scholar
• Huuskonen A, Mäkitie A, Sihvo E. ikuisten henkitorven ahtaumien kirurginen hoito [Treatment of adult tracheal stenosis]. Duodecim; laaketieteellinen aikakauskirja. 2015;131(19):1793–1801.
   PubMedGoogle Scholar
• Whited CW, Dailey SH. Is mitomycin C useful as an adjuvant therapy in endoscopic treatment of laryngotracheal stenosis? Laryngoscope. 2015;125(10):2243–2244.
   PubMed Web of Science ®Google Scholar
• Shadmehr MB, Abbasidezfouli A, Farzanegan R, et al. The role of systemic steroids in postintubation tracheal stenosis: a randomized clinical trial. Ann Thorac Surg. 2017;103(1):246–253.
   PubMed Web of Science ®Google Scholar
• Hu HH, Chen DQ, Wang YN, et al. New insights into TGF-beta/Smad signaling in tissue fibrosis. Chem Biol Interact. 2018;292:76–83.
   PubMed Web of Science ®Google Scholar
• Margadant C, Sonnenberg A. Integrin-TGF-beta crosstalk in fibrosis cancer and wound healing. EMBO Rep. 2010;11(2):97–105.
   PubMed Web of Science ®Google Scholar
• Lamouille S, Derynck R. Cell size and invasion in TGF-β–induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol. 2007;178(3):437–451.
   PubMed Web of Science ®Google Scholar
• Ashcroft G, Ashcroft G, Yang X, et al. Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory respons. Nat Cell Biol. 1999;1(5):260–266.
   PubMed Web of Science ®Google Scholar
• Evans R, Tian Y, Steadman R, et al. TGF-beta1-mediated fibroblast-myofibroblastterminal differentiation-the role of Smad proteins. Exp Cell Res. 2003;282(2):90–100.
   PubMed Web of Science ®Google Scholar
• Zhang YE. Non-Smad Signaling Pathways of the TGF-beta Family. Cold Spring Harb Perspect Biol. 2017;9(2):2.
   Web of Science ®Google Scholar
• Bakin AV, Tomlinson AK, Bhowmick NA, et al. Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration. J Biol Chem. 2000;275(47):36803–36810.
   PubMed Web of Science ®Google Scholar
• Saxton RA, Sabatini DM. mTOR signaling in growth metabolism, and disease. Cell. 2017;169(2):361–371.
   PubMed Web of Science ®Google Scholar
• Mercer PF, Woodcock HV, Eley JD, et al. Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF. Thorax. 2015;71(8):701–711.
   Web of Science ®Google Scholar
• Padhye S, Dandawate P, Yusufi M, et al. Perspectives on medicinal properties of plumbagin and its analogs. Med Res Rev. 2012;32(6):1131–1158.
   PubMed Web of Science ®Google Scholar
• Panichayupakaranant P, Ahmad MI. Plumbagin and Its Role in Chronic Diseases. Adv Exp Med Biol. 2016,929: 229–246. https://doi.org/10.1007/978-3-319-41342-6_10 .
   Google Scholar
• Zhang R, Wang Z, You W, et al. Suppressive effects of plumbagin on the growth of human bladder cancer cells via PI3K/Akt/mTOR signaling pathways and EMT. Cancer Cell Int. 2020;20(1):520.
   PubMed Web of Science ®Google Scholar
• Wu H, Dai X, Wang E. Plumbagin inhibits cell proliferation and promotes apoptosis in multiple myeloma cells through inhibition of the PI3K/Akt-mTOR pathway. Oncol Lett. 2016;12(5):3614–3618.
   PubMed Web of Science ®Google Scholar
• Shao Y, Dang M, Lin Y, et al. Evaluation of wound healing activity of plumbagin in diabetic rats. Life Sci. 2019;231:116422.
   PubMed Web of Science ®Google Scholar
• Lee SY, Kim MJ, Jang S, et al. Plumbagin suppresses pulmonary fibrosis via inhibition of p300 histone acetyltransferase activity. J Med Food. 2020;23(6):633–640.
   PubMed Web of Science ®Google Scholar
• Ershova ES, Sergeeva VA, Chausheva AI, et al. Toxic and DNA damaging effects of a functionalized fullerene in human embryonic lung fibroblasts. Mutat Res Genet Toxicol Environ Mutagen. 2016;805:46–57.
   PubMed Web of Science ®Google Scholar
• Wang H, Zhang H, Zhang Y, et al. Plumbagin protects liver against fulminant hepatic failure and chronic liver fibrosis via inhibiting inflammation and collagen production. Oncotarget. 2016;7(50):82864–82875.
   PubMedGoogle Scholar
• Mizokami D, Araki K, Tanaka N, et al. Sendai virus transgene in a novel gene therapy for laryngotracheal disease. Laryngoscope. 2013;123(7):1717–1724.
   PubMed Web of Science ®Google Scholar
• Zheng XY, Mao CY, Qiao H, et al. Plumbagin suppresses chronic periodontitis in rats via down-regulation of TNF-α, IL-1β and IL-6 expression. Acta Pharmacol Sin. 2017;38(8):1150–1160.
   PubMed Web of Science ®Google Scholar
• Lee HS, Jeong MS, Ko SC, et al. Fabrication and biological activity of polycaprolactone/phlorotannin endotracheal tube to prevent tracheal stenosis: an in vitro and in vivo study. J Biomed Mater Res B Appl Biomater. 2020;108(3):1046–1056.
   PubMed Web of Science ®Google Scholar
• Fischer AH, Jacobson KA, Rose J, et al. (2008) Hematoxylin and eosin staining of tissue and cell sections. CSH Protoc 2008: pdbprot4986. 10.1101/pdb.prot4986
   Google Scholar
• Gelbard A, Francis DO, Sandulache VC, et al. Causes and consequences of adult laryngotracheal stenosis. Laryngoscope. 2014;125(5):1137–1143.
   PubMed Web of Science ®Google Scholar
• Gurtner GC, Werner S, Barrandon Y, et al. Wound repair and regeneration. Nature. 2008;453(7193):314–321.
   PubMed Web of Science ®Google Scholar
• Yong R, Chen XM, Shen S, et al. Plumbagin ameliorates diabetic nephropathy via interruption of pathways that include NOX4 signalling. PLoS One. 2013;8(8):e73428.
   PubMed Web of Science ®Google Scholar
• Karagiannidis C, Velehorschi V, Obertrifter B, et al. High-level expression of matrix-associated transforming growth factor-beta1 in benign airway stenosis. Chest. 2006;129(5):5.
   PubMed Web of Science ®Google Scholar
• Xue C, Lin XP, Zhang JM, et al. beta-Elemene suppresses the proliferation of human airway granulation fibroblasts via attenuation of TGF-beta/Smad signaling pathway. J Cell Biochem. 2019;120(10):16553–16566. published Online First: 2019/05/20.
   PubMed Web of Science ®Google Scholar
• Woodcock HV, Eley JD, Guillotin D, et al. The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis. Nat Commun. 2019;10(1):1.
   PubMedGoogle Scholar
• He J, Peng H, Wang M, et al. Isoliquiritigenin inhibits TGF-beta1-induced fibrogenesis through activating autophagy via PI3K/Akt/mTOR pathway in MRC-5 cells. Acta Biochim Biophys Sin (Shanghai). 2020;52(8):810–820.
   PubMed Web of Science ®Google Scholar
• Gao Y, Xu X, Ding K, et al. Rapamycin inhibits transforming growth factor beta1-induced fibrogenesis in primary human lung fibroblasts. Yonsei Med J. 2013;54(2):437–444.
   PubMed Web of Science ®Google Scholar
• Namba DR, Ma G, Samad I, et al. Rapamycin inhibits human laryngotracheal stenosis–derived fibroblast proliferationmetabolism, and function in vitro. Otolaryngol Head Neck Surg. 2015;152(5):881–888.
   PubMed Web of Science ®Google Scholar